Toripalimab Plus TPF Chemotherapy and Radiotherapy for LA-HPSCC

Summary

TPF is the standard regime of inductive chemotherapy for squamous carcinoma of head and neck. If the primary tumor shrinks obviously (complete remission or \>75% partial remission )after inductive chemotherapy, CCRT is suggested as the definitive therapy, for the tumor is sensitive to chemotherapy. If the primary tumor shrinks a little or progresses after inductive chemotherapy, operation is suggested as the definitive therapy to get a longer survival.

Timeline

Start

2020-10-30

Primary completion

2025-10-30

Completion

2025-12-30

Drugs

Indications